Baseline Evaluation of Lymph Nodes in the Lower Quadrant Young People Using Point of Care Ultrasound (BELLY-POCUS) (BELLY POCUS)

Baseline Evaluation of Lymph Nodes in the Lower Quadrant Young People Using Point of Care Ultrasound

Abdominal pain is one of the commonest presentations to the paediatric emergency department. Many children are brought to the PED due to concerns about surgical intra-abdominal pathology such as appendicitis. Mesenteric adenitis is commonly attributed as a cause of the patient's pain but is done so without confirmatory imaging findings and as a diagnosis of exclusion.

There is a paucity of evidence pertaining to the sonographic findings of mesenteric adenitis.

We aim to categorise the normal appearances using POCUS in patients presenting to the paediatric emergency department without any abdominal or infectious complaint, in order to describe the range of normal lymph node numbers and size present on scan. By defining what's normal, the ultimate aim will be to use POCUS to actively identify abnormalities that diagnose mesenteric adenitis.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients who present to the paediatric emergency department with the following conditions: head injury, facial injury, neck injury, upper and lower limb injury.

This will take place across 5 hospital sites in the UK, USA and Australia

Description

Inclusion Criteria:

- patients aged 2 - 16 years who present to the paediatric emergency department with the following conditions: head injury, facial injury, neck injury, upper and lower limb injury.

Exclusion Criteria:

  • any child who has had symptoms of vomiting (including those with concurrent head injury), diarrhoea, abdominal pain, anorexia, temperature or active evidence of urinary or respiratory tract infection within the last four weeks.

Any patient who has undergone abdominal surgery in the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number and sizes of lymph nodes present in the right lower quadrant on abdominal POCUS
Time Frame: 6 months
To describe the normal range, in terms of the number and size of lymph nodes present in the right lower quadrant on abdominal POCUS in asymptomatic children.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 9, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

July 9, 2026

First Submitted That Met QC Criteria

July 9, 2026

First Posted (Actual)

July 15, 2026

Study Record Updates

Last Update Posted (Actual)

July 15, 2026

Last Update Submitted That Met QC Criteria

July 9, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Awaited

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lymph Nodes

3
Subscribe